Free Trial

InMed Pharmaceuticals (INM) Insider Trading & Ownership

InMed Pharmaceuticals logo
$3.70 -0.58 (-13.55%)
(As of 10:06 AM ET)

InMed Pharmaceuticals (NASDAQ:INM) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.85%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$29,601.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get INM Insider Trade Alerts

Want to know when executives and insiders are buying or selling InMed Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

INM Insider Buying and Selling by Quarter

InMed Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/21/2024Andrew HullDirectorBuy1,875$7.80$14,625.00  
2/20/2024Eric A AdamsCEOBuy2,080$7.20$14,976.00  
(Data available from 1/1/2013 forward)

INM Insider Trading Activity - Frequently Asked Questions

The list of insiders at InMed Pharmaceuticals includes Andrew Hull, Bruce Colwill, Eric A Adams, and Shane Aaron Johnson. Learn more on insiders at INM.

1.85% of InMed Pharmaceuticals stock is owned by insiders. Learn more on INM's insider holdings.

The following insiders have purchased INM shares in the last 24 months: Andrew Hull ($14,625.00), and Eric A Adams ($14,976.00).

Insiders have purchased a total of 3,955 INM shares in the last 24 months for a total of $29,601.00 bought.

InMed Pharmaceuticals Key Executives

  • Mr. Eric A. Adams B.S. Chem. (Age 61)
    M.I.B., President, CEO & Director
    Compensation: $347.82k
  • Mr. Michael Woudenberg P.Eng. (Age 55)
    Chief Operating Officer
    Compensation: $287.54k
  • Ms. Alexandra Diane-Janet Mancini M.Sc. (Age 71)
    Senior Vice President of Clinical & Regulatory Affairs
    Compensation: $279.39k
  • Dr. Sazzad Hossain M.Sc. (Age 66)
    Ph.D., Co-Founder
    Compensation: $137.33k
  • Ms. N. Netta Jagpal (Age 51)
    CFO & Corporate Secretary
  • Ms. Sarah Li CPA
    CGA, VP of Accounting & Controller
  • Colin Clancy
    Senior Director of Investor Relations
  • Mr. Jerry P. Griffin
    Vice President of Sales & Marketing
  • Dr. Eric Chih-Hsien Hsu (Age 54)
    Senior Vice President of Preclinical Research & Development
    Compensation: $253.46k
  • Dr. Shane A. Johnson Ph.D.
    Senior VP & GM of BayMedica


This page (NASDAQ:INM) was last updated on 11/18/2024 by MarketBeat.com Staff
From Our Partners